MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 05-05-2023
Heska Corporation Operating Cash Flow 2011-2025 | HSKA
Annual Operating Cash Flow Heska Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -21.8 M | 6.25 M | -656 K | 3.3 M | 13.3 M | 10.4 M | 5.86 M | 2.12 M | 5.55 M | -1.41 M | -369 K | 4.89 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.3 M | -21.8 M | 2.28 M |
Quarterly Operating Cash Flow Heska Corporation
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.16 M | - | -18.7 M | -16.6 M | -17.7 M | - | 5.27 M | 7.15 M | 1.34 M | - | -8.1 M | -13.1 M | -4.76 M | - | -3.28 M | -5.36 M | 727 K | - | 6.46 M | 4.5 M | 4.21 M | - | 6.28 M | 4.86 M | 1.93 M | - | 1.88 M | 278 K | -637 K | - | -932 K | -282 K | -1.39 M | - | 3.6 M | 3.16 M | 5.22 M | - | -1.26 M | -1.06 M | 510 K | - | 1.02 M | 2.07 M | -255 K | - | 5.62 M | 3.57 M | -151 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 7.15 M | -18.7 M | -892 K |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Brainsway Ltd.
BWAY
|
884 K | $ 18.7 | -3.44 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-478 M | $ 20.72 | -3.9 % | $ 223 M |  China |
 |
Co-Diagnostics
CODX
|
-22.1 M | $ 0.23 | -4.09 % | $ 6.75 M | USA |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
64.9 M | $ 39.24 | -0.39 % | $ 1.09 B | USA |
 |
Danaher Corporation
DHR
|
6.69 B | $ 230.65 | 0.13 % | $ 169 B | USA |
 |
DarioHealth Corp.
DRIO
|
-30.4 M | $ 10.65 | 6.03 % | $ 302 M | Israel |
 |
BioNano Genomics
BNGO
|
-68.9 M | $ 1.5 | -1.32 % | $ 1.91 M | USA |
 |
Exact Sciences Corporation
EXAS
|
211 M | $ 101.58 | 0.01 % | $ 18.8 B | USA |
 |
DexCom
DXCM
|
748 M | $ 67.74 | 0.25 % | $ 26.1 B | USA |
 |
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
21.1 M | $ 26.54 | -0.67 % | $ 802 M | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
-18.4 M | $ 19.01 | -2.41 % | $ 1.02 B | USA |
 |
Celcuity
CELC
|
-83.5 M | $ 101.78 | -0.46 % | $ 4.02 B | USA |
 |
Anixa Biosciences
ANIX
|
-7.34 M | $ 3.2 | - | $ 102 K | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
2.72 B | $ 226.28 | -0.28 % | $ 41 B | USA |
 |
Guardant Health
GH
|
-240 M | $ 101.9 | -1.05 % | $ 12.5 B | USA |
 |
Aspira Women's Health
AWH
|
-32.2 M | - | -6.19 % | $ 10.5 M | USA |
 |
Myriad Genetics
MYGN
|
-8.7 M | $ 6.35 | -2.08 % | $ 575 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-7.4 M | $ 4.96 | -2.36 % | $ 2.66 M | USA |
 |
Neogen Corporation
NEOG
|
58.2 M | $ 7.16 | 0.35 % | $ 1.55 B | USA |
 |
National Research Corporation
NRC
|
38.1 M | $ 18.73 | 0.38 % | $ 460 M | USA |
 |
Illumina
ILMN
|
837 M | $ 134.09 | -0.64 % | $ 21.3 B | USA |
 |
Charles River Laboratories International
CRL
|
735 M | $ 202.78 | -0.38 % | $ 10.4 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.33 B | $ 174.97 | -0.56 % | $ 19.4 B | USA |
|
Biodesix
BDSX
|
-48.6 M | $ 6.6 | -3.19 % | $ 856 M | USA |
 |
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
1.59 B | $ 252.66 | -0.51 % | $ 21.2 B | USA |
 |
ICON Public Limited Company
ICLR
|
1.29 B | $ 181.48 | -0.74 % | $ 15 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
929 M | $ 682.84 | -0.82 % | $ 56.3 B | USA |
 |
Lantheus Holdings
LNTH
|
545 M | $ 66.94 | 0.34 % | $ 4.63 B | USA |
 |
Mettler-Toledo International
MTD
|
968 M | $ 1 412.33 | -0.55 % | $ 30 B |  Schweiz |
 |
Agilent Technologies
A
|
1.48 B | $ 137.93 | -0.33 % | $ 41.9 B | USA |
 |
Biomerica
BMRA
|
-3.84 M | $ 2.7 | - | $ 6.2 M | USA |
 |
Bioventus
BVS
|
15.3 M | $ 7.49 | 0.4 % | $ 469 M | USA |
 |
Personalis
PSNL
|
-45.2 M | $ 8.13 | -0.12 % | $ 482 M | USA |